These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 15737123

  • 1. Evaluating the accuracy of Malformations Surveillance Program in detecting virilization due to congenital adrenal hyperplasia.
    Travitz J, Westgate MN, Larson C, Holmes LB.
    Congenit Anom (Kyoto); 2005 Mar; 45(1):1-4. PubMed ID: 15737123
    [Abstract] [Full Text] [Related]

  • 2. Newborn screening for congenital adrenal hyperplasia has reduced sensitivity in girls.
    Varness TS, Allen DB, Hoffman GL.
    J Pediatr; 2005 Oct; 147(4):493-8. PubMed ID: 16227036
    [Abstract] [Full Text] [Related]

  • 3. Congenital adrenal hyperplasia: problems with developmental anomalies of the external genitalia and sex assignment.
    Al-Maghribi H.
    Saudi J Kidney Dis Transpl; 2007 Sep; 18(3):405-13. PubMed ID: 17679754
    [Abstract] [Full Text] [Related]

  • 4. A comparative cost analysis of newborn screening for classic congenital adrenal hyperplasia in Texas.
    Brosnan CA, Brosnan P, Therrell BL, Slater CH, Swint JM, Annegers JF, Riley WJ.
    Public Health Rep; 1998 Sep; 113(2):170-8. PubMed ID: 9719819
    [Abstract] [Full Text] [Related]

  • 5. Two-year pilot study of newborn screening for congenital adrenal hyperplasia in New South Wales compared with nationwide case surveillance in Australia.
    Gleeson HK, Wiley V, Wilcken B, Elliott E, Cowell C, Thonsett M, Byrne G, Ambler G.
    J Paediatr Child Health; 2008 Oct; 44(10):554-9. PubMed ID: 19012627
    [Abstract] [Full Text] [Related]

  • 6. [Congenital adrenal hyperplasia salt-wasting form in males during the neonatal period. Can we anticipate to metabolic emergency?].
    Gebara E, Fernández MA, Rojas E, Amin A, López MR.
    Arch Argent Pediatr; 2009 Aug; 107(4):369-73. PubMed ID: 19753447
    [Abstract] [Full Text] [Related]

  • 7. A case of 11beta-hydroxylase deficiency detected in a newborn screening program by second-tier LC-MS/MS.
    Peter M, Janzen N, Sander S, Korsch E, Riepe FG, Sander J.
    Horm Res; 2008 Aug; 69(4):253-6. PubMed ID: 18204274
    [Abstract] [Full Text] [Related]

  • 8. Use of steroid profiling by UPLC-MS/MS as a second tier test in newborn screening for congenital adrenal hyperplasia: the Utah experience.
    Schwarz E, Liu A, Randall H, Haslip C, Keune F, Murray M, Longo N, Pasquali M.
    Pediatr Res; 2009 Aug; 66(2):230-5. PubMed ID: 19390483
    [Abstract] [Full Text] [Related]

  • 9. [Neonatal screening for congenital adrenal hyperplasia in Shanghai areas].
    Gu X, Zhou J, Ye J.
    Zhonghua Yu Fang Yi Xue Za Zhi; 2002 Jan; 36(1):16-8. PubMed ID: 11955341
    [Abstract] [Full Text] [Related]

  • 10. [Congenital adrenal hyperplasia: clinical aspects and neonatal screening].
    Stikkelbroeck MM, Otten BJ.
    Ned Tijdschr Geneeskd; 2002 Feb 09; 146(6):246-9. PubMed ID: 11865652
    [Abstract] [Full Text] [Related]

  • 11. [Virilization caused by 21-hydroxylase deficiency and axillary sweat gland hyperplasia].
    Jourdain JC, Le Lorier B, Mourier C, Ploussard JP, Roussel F.
    Ann Dermatol Venereol; 1988 Feb 09; 115(11):1136-8. PubMed ID: 3266452
    [No Abstract] [Full Text] [Related]

  • 12. Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden.
    Thil'en A, Nordenström A, Hagenfeldt L, von Döbeln U, Guthenberg C, Larsson A.
    Pediatrics; 1998 Apr 09; 101(4):E11. PubMed ID: 9521977
    [Abstract] [Full Text] [Related]

  • 13. Update: newborn screening for endocrinopathies.
    Pass KA, Neto EC.
    Endocrinol Metab Clin North Am; 2009 Dec 09; 38(4):827-37. PubMed ID: 19944295
    [Abstract] [Full Text] [Related]

  • 14. Postnatal virilization mimicking 21-hydroxylase deficiency in 3 very premature infants.
    Couch R, Girgis R.
    Pediatrics; 2012 May 09; 129(5):e1364-7. PubMed ID: 22473363
    [Abstract] [Full Text] [Related]

  • 15. [Total virilization in a girl with adrenogenital syndrome].
    Hoepffner W, Sandig KR.
    Kinderarztl Prax; 1971 Aug 09; 39(8):356-61. PubMed ID: 5137364
    [No Abstract] [Full Text] [Related]

  • 16. Efficiency of neonatal screening for congenital adrenal hyperplasia due to 21-hydroxylase deficiency in children born in mainland France between 1996 and 2003.
    Coulm B, Coste J, Tardy V, Ecosse E, Roussey M, Morel Y, Carel JC, DHCSF Study Group.
    Arch Pediatr Adolesc Med; 2012 Feb 09; 166(2):113-20. PubMed ID: 22312171
    [Abstract] [Full Text] [Related]

  • 17. A case of 3beta-hydroxysteroid dehydrogenase type II (HSD3B2) deficiency picked up by neonatal screening for 21-hydroxylase deficiency: difficulties and delay in etiologic diagnosis.
    Nordenström A, Forest MG, Wedell A.
    Horm Res; 2007 Feb 09; 68(4):204-8. PubMed ID: 17496421
    [Abstract] [Full Text] [Related]

  • 18. Steroid responsive hypertension secondary to 11-beta hydroxylase deficiency--a case report.
    Isiavwe AR, Ekpebegh CO, Fasanmade OA, Ohwovoriole AE.
    West Afr J Med; 2008 Jul 09; 27(3):182-5. PubMed ID: 19256327
    [Abstract] [Full Text] [Related]

  • 19. Inclusion and exclusion criteria for malformations in newborn infants exposed to potential teratogens.
    Holmes LB, Westgate MN.
    Birth Defects Res A Clin Mol Teratol; 2011 Sep 09; 91(9):807-12. PubMed ID: 21800414
    [Abstract] [Full Text] [Related]

  • 20. Diagnosis of adrenocortical tumor in a neonate by detection of elevated blood 17-hydroxyprogesterone measured as a routine neonatal screening for congenital adrenal hyperplasia: a case report.
    Hishiki T, Kazukawa I, Saito T, Terui K, Mitsunaga T, Nakata M, Matsuura G, Minagawa M, Kohno Y, Yoshida H.
    J Pediatr Surg; 2008 Oct 09; 43(10):e19-22. PubMed ID: 18926198
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.